Splicing regulation of DNA repair via CCAR1
- PMID: 39059366
- DOI: 10.1016/j.molcel.2024.06.012
Splicing regulation of DNA repair via CCAR1
Abstract
In this issue of Molecular Cell, Harada et al.1 and Karasu et al.2 identify CCAR1 as a novel regulator of the Fanconi anemia/BRCA DNA repair pathway via modulating the splicing of the mRNA encoding FANCA.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests O.A.-W. is a founder and scientific advisor of Codify Therapeutics, holds equity in this company, and receives research funding from this company. O.A.-W. has served as a consultant for Foundation Medicine, Inc.; Merck; Prelude Therapeutics; Amphista Therapeutics; MagnetBio; and Janssen and is on the scientific advisory board of Envisagenics, Inc.; Harmonic Discovery, Inc.; and Pfizer Boulder. O.A.-W. has received prior research funding from H3B Biomedicine, Nurix Therapeutics, Minovia Therapeutics, and LOXO Oncology unrelated to the current manuscript.
Comment on
-
The splicing factor CCAR1 regulates the Fanconi anemia/BRCA pathway.Mol Cell. 2024 Jul 25;84(14):2618-2633.e10. doi: 10.1016/j.molcel.2024.06.031. Epub 2024 Jul 17. Mol Cell. 2024. PMID: 39025073 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
